| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 9, 2026 | Kainova Therapeutics | $23.5M Series B | Investissement Quebec | 3B Future Health Fund, adMare Bio Innovations, Panacea Venture, Schroders Capital, Seido Capital, Seventure Partners, Turenne Capital, Viva BioInnovator |